Back

The protection of Gαz-null NOD mice from hyperglycemia is sexually dimorphic and only partially β-cell autonomous

Fenske, R. J.; Peter, D. C.; Wienkes, H. N.; Schaid, M. D.; Reuter, A.; Carbajal, K. A.; Kimple, M. E.

2021-02-09 physiology
10.1101/2021.02.08.430304 bioRxiv
Show abstract

The mechanisms that underlie the {beta}-cell pathophysiology of Type 1 Diabetes (T1D) are not fully understood. Our group has defined the unique heterotrimeric G protein alpha-subunit, Gz, as a key negative regulator of {beta}-cell signal transduction pathways. Non-obese diabetic (NOD) mice lacking Gz throughout the body are protected from developing T1D-like hyperglycemia. To determine whether this phenotype is {beta}-cell autonomous, we generated and validated a {beta}-cell-specific Gz knockout ({beta}KO) on the NOD background and characterized the phenotype of female and male cohorts. Long-term hyperglycemia incidence was lower in Gz {beta}KO mice as compared to wild-type (WT) controls, but, unlike global Gz knockout mice, this protection was incomplete. While young male and female Gz {beta}KO NOD mice had improved glucose tolerance, WT NOD males were significantly less glucose tolerant than females, and only female Gz {beta}KO mice retained improved glucose tolerance at 28-29 weeks of age. Conversely, {beta}-cell-specific Gz loss only influenced insulitis in 28-29-week old male NOD mice, a phenotype correlating directly with body burden of glucose during oral glucose challenge. Using surrogates for {beta}-cell function and apoptosis, the partial penetrance of euglycemia in Gz {beta}KO NOD was best explained by an early failure to up-regulate {beta}-cell proliferation. We conclude {beta}-cell Gz is an important regulator of the sexually-dimorphic T1D-like phenotype of NOD mice. Yet, other factors must be important in imparting full protection from the disease.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Diabetes
53 papers in training set
Top 0.1%
27.9%
2
Diabetologia
36 papers in training set
Top 0.1%
14.8%
3
Cell Reports
1338 papers in training set
Top 3%
9.2%
50% of probability mass above
4
Journal of Clinical Investigation
164 papers in training set
Top 0.3%
6.4%
5
Molecular Metabolism
105 papers in training set
Top 0.3%
6.4%
6
JCI Insight
241 papers in training set
Top 0.9%
4.3%
7
Nature Communications
4913 papers in training set
Top 42%
3.3%
8
PLOS Genetics
756 papers in training set
Top 7%
2.1%
9
eLife
5422 papers in training set
Top 38%
1.9%
10
PLOS ONE
4510 papers in training set
Top 51%
1.8%
11
The Journal of Clinical Endocrinology & Metabolism
35 papers in training set
Top 0.7%
1.7%
12
Frontiers in Endocrinology
53 papers in training set
Top 1%
1.5%
13
Endocrinology
38 papers in training set
Top 0.4%
1.3%
14
Scientific Reports
3102 papers in training set
Top 70%
0.9%
15
EMBO reports
136 papers in training set
Top 6%
0.8%
16
Journal of Biological Chemistry
641 papers in training set
Top 4%
0.8%
17
BMJ Open Diabetes Research & Care
15 papers in training set
Top 1%
0.8%
18
PLOS Biology
408 papers in training set
Top 21%
0.7%
19
Cell Reports Medicine
140 papers in training set
Top 8%
0.7%
20
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 45%
0.7%
21
The Journal of Physiology
134 papers in training set
Top 2%
0.6%
22
American Journal of Physiology-Endocrinology and Metabolism
34 papers in training set
Top 0.5%
0.5%
23
Matrix Biology
28 papers in training set
Top 0.5%
0.5%